Who We Are
Vision
Team
International
Sponsors
Partners
Companies
Entrepreneurs
Why Apply to Golden Seeds
Investment Criteria
Apply for Funding
Process & Timing
Information Sessions and Office Hours
Membership
About Angel Investing
Golden Seeds Angel Network
Golden Seeds Annual Fund
Interested in Joining?
Funds
Knowledge Institute
Investor Training
Course Schedule & Registration
Blog & News
Golden Seeds Blog
Golden Seeds News
Companies’ News
Contact Us
Who We Are
Vision
Team
International
Sponsors
Partners
Companies
Entrepreneurs
Why Apply to Golden Seeds
Investment Criteria
Apply for Funding
Process & Timing
Information Sessions and Office Hours
Membership
About Angel Investing
Golden Seeds Angel Network
Golden Seeds Annual Fund
Interested in Joining?
Funds
Knowledge Institute
Investor Training
Course Schedule & Registration
Blog & News
Golden Seeds Blog
Golden Seeds News
Companies’ News
Contact Us
Search
Entrepreneur Login
Member Login
Sign Up For Our Newsletter
Email Newsletter Signup
Name
Email
Company
Submit
Facebook
Linkedin
Twitter
Who We Are
Vision
Team
International
Sponsors
Partners
Companies
Entrepreneurs
Why Apply to Golden Seeds
Investment Criteria
Apply for Funding
Process & Timing
Information Sessions and Office Hours
Membership
About Angel Investing
Golden Seeds Angel Network
Golden Seeds Annual Fund
Interested in Joining?
Funds
Knowledge Institute
Investor Training
Course Schedule & Registration
Blog & News
Golden Seeds Blog
Golden Seeds News
Companies’ News
Contact Us
Who We Are
Vision
Team
International
Sponsors
Partners
Companies
Entrepreneurs
Why Apply to Golden Seeds
Investment Criteria
Apply for Funding
Process & Timing
Information Sessions and Office Hours
Membership
About Angel Investing
Golden Seeds Angel Network
Golden Seeds Annual Fund
Interested in Joining?
Funds
Knowledge Institute
Investor Training
Course Schedule & Registration
Blog & News
Golden Seeds Blog
Golden Seeds News
Companies’ News
Contact Us
Blog >
4/29/21
4/29/21
May 12, 2021
Pfizer acquires Golden Seeds company
Amplyx Pharma
to expand drug-resistant treatment portfolio. Congratulations to Ciara Kennedy and her team!
